Rexlemestrocel-l clinical trials
Also written NeoFuse.
How each study uses rexlemestrocel-l is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses rexlemestrocel-l is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart FailureCompletedPhase 3Mesoblast, Inc.NCT02032004Written as Rexlemestrocel-L
- Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back PainCompletedPhase 3Mesoblast, Ltd.NCT02412735Written as Rexlemestrocel-L
- Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and FusionCompletedPhase 1/2Mesoblast, Ltd.NCT01106417Written as NeoFuse
- Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)CompletedPhase 1/2Mesoblast, Ltd.NCT00549913Written as NeoFuse
- Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical DiscectomyCompletedPhase 2Mesoblast, Ltd.NCT01097486Written as NeoFuse
Codes
What other systems call rexlemestrocel-l · ClinicalTrials.gg INT014895
- UNII (FDA) 4LS0IJZ59VREXLEMESTROCEL-LOne source FDA
- NCI Thesaurus C171655Rexlemestrocel-LOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4LS0IJZ59V | REXLEMESTROCEL-L | One source FDA |
| NCI Thesaurus | C171655 | Rexlemestrocel-L | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.